SKI Market

A+| A| A-|

Indian Indices

Sensex

72,534.26 -1,048.96
( -1.43%)

Global Indices

Nasdaq

45,202.56 -778.56
(-1.69%)

Dow Jones

6,394.42 -103.74
(-1.60%)

Hang Seng

53,412.46 -191.19
(-0.36%)

Nikkei 225

9,959.27 -12.90
(-0.13%)

Forex

USD-INR

94.09 0.23
(0.24%)

EUR-INR

108.64 -0.12
(-0.11%)

GBP-INR

125.57 -0.09
(-0.07%)

JPY-INR

0.59 0.00
(-0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Everest Organics Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524790

INE334C01029

74.6694113

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

38.78

225.92

EPS(TTM)

Face Value()

Div & Yield %

Back

hindustan unilever ltd

Vaxfab Enterprises standalone net profit declines 96.43% in the December 2025 quarter

Feb 15,2026

Net profit of Vaxfab Enterprises declined 96.43% to Rs 0.23 crore in the quarter ended December 2025 as against Rs 6.44 crore during the previous quarter ended December 2024. Sales declined 65.05% to Rs 15.66 crore in the quarter ended December 2025 as against Rs 44.81 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	15.66	44.81	-65
OPM %	2.55	14.22	-
PBDT	0.40	6.46	-94
PBT	0.39	6.44	-94
NP	0.23	6.44	-96

72,534.26 -1,048.96 ( -1.43%)

45,202.56 -778.56 (-1.69%)

6,394.42 -103.74 (-1.60%)

53,412.46 -191.19 (-0.36%)

9,959.27 -12.90 (-0.13%)

94.09 0.23 (0.24%)

108.64 -0.12 (-0.11%)

125.57 -0.09 (-0.07%)

0.59 0.00 (-0.07%)